Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Australia consults on third-party conformity assessment

This article was originally published in SRA

Executive Summary

Australia’s Therapeutic Goods Administration may begin allowing third-party conformity assessment bodies to examine and certify the quality systems of local medical device manufacturers1. To that end, it has released a consultation document that outlines the principal issues to be considered, the most important of which is determining an appropriate balance in the use of CABs to ensure the timely availability of safe and effective medical devices2. Comments are due by 27 March.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT038462

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel